Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2003-04-16
2009-11-03
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C536S023100, C536S023700, C530S300000, C530S350000, C424S009100, C424S009200, C424S185100, C424S190100, C424S243100, C435S007100, C435S007200
Reexamination Certificate
active
07611720
ABSTRACT:
The invention relates to a live recombinantMycobacterium bovis-BCG strain comprising a nucleic acid capable of expression, the nucleic acid encoding at least one protein or polypeptide that exhibits alanine dehydrogenase activity, glutamine synthetase activity, or serine dehydratase activity.
REFERENCES:
patent: WO 00/11214 (2000-03-01), None
patent: WO 01/078774 (2001-10-01), None
TB Vaccines: Progress and Problems; Trends in Immunology, vol. 22, Issue 3, dated Mar. 1, 2001, pp. 160-168.
Long-Term Maintenance Bacille Calmette-Guerin Therapy in High-Grade Superficial Bladder Cancer; Urology, vol. 59, Issue 3, dated Mar. 2002, pp. 414-418.
Glutamine Synthetase ofMycobacterium tuberculosis: Extracellular Release and Characterization of its Enzymatic Activity; Proc. Natl. Acad. Sci. USA, vol. 91, dated Sep. 1994, pp. 9342-9346.
An Inhibitor of ExportedMycobacterium tuberculosisGlutamine Synthetase Selectively Blocks the Growth of Pathogenic Mycobacteria in Axenic Culture and in Human Monocytes: Extracellular Proteins as Potential Novel Drug Targets; Department of Medicine, University of California at Los Angeles School of Medicine, vol. 189, No. 9, dated May 3, 1999, pp. 1425-1435.
Mycobacterium bovisBCG Vaccines Exhibit Defects in Alanine and Serine Catabolism; Infection and Immunity, Feb. 2003, pp. 708-716.
Alexander David
Chen Jeffrey
Liu Jun
Liu Jun
Swartz Rodney P.
LandOfFree
Tuberculosis vaccines including recombinant BCG strains... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tuberculosis vaccines including recombinant BCG strains..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tuberculosis vaccines including recombinant BCG strains... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4136107